Marwan G. Fakih
GI Oncology
Department of Medicine
Roswell Park Cancer Institute
Elm and Carlton streets
U.S.A
Name/email consistency: high
- First-line Cisplatin Plus Etoposide in High-grade Metastatic Neuroendocrine Tumors of Colon and Rectum (MCRC NET): Review of 8 Cases. Patta, A., Fakih, M. Anticancer Res. (2011)
- Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancer. Fakih, M.G. Future. Oncol (2011)
- A phase I, pharmacokinetic, and pharmacodynamic study of two schedules of vorinostat in combination with 5-fluorouracil and leucovorin in patients with refractory solid tumors. Fakih, M.G., Fetterly, G., Egorin, M.J., Muindi, J.R., Espinoza-Delgado, I., Zwiebel, J.A., Litwin, A., Holleran, J.L., Wang, K., Diasio, R.B. Clin. Cancer Res. (2010)
- KRAS mutation screening in colorectal cancer: From paper to practice. Fakih, M.M. Clin. Colorectal. Cancer (2010)
- Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Fakih, M.G., Trump, D.L., Johnson, C.S., Tian, L., Muindi, J., Sunga, A.Y. Int. J. Colorectal. Dis (2009)
- Does celecoxib have a role in the treatment of patients with colorectal cancer? Fakih, M.G., Rustum, Y.M. Clin. Colorectal. Cancer (2009)
- A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer. Fakih, M.G., Pendyala, L., Fetterly, G., Toth, K., Zwiebel, J.A., Espinoza-Delgado, I., Litwin, A., Rustum, Y.M., Ross, M.E., Holleran, J.L., Egorin, M.J. Clin. Cancer Res. (2009)
- A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors. Fakih, M.G., Pendyala, L., Brady, W., Smith, P.F., Ross, M.E., Creaven, P.J., Badmaev, V., Prey, J.D., Rustum, Y.M. Cancer Chemother. Pharmacol. (2008)
- The role of targeted therapy in the treatment of advanced colorectal cancer. Fakih, M. Curr. Treat. Options. Oncol (2008)
- Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia. Fakih, M. Oncology (Williston Park, N.Y.) (2008)
- Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?. Fakih, M. Expert. Rev. Anticancer. Ther (2008)
- Increased frequency of uridine diphosphate glucuronosyltransferase 1A1 7/7 in patients experiencing severe irinotecan-induced toxicities. Fakih, M.G., Ross, M.E., Starostik, P. Clin. Colorectal. Cancer (2007)
- A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Fakih, M.G., Trump, D.L., Muindi, J.R., Black, J.D., Bernardi, R.J., Creaven, P.J., Schwartz, J., Brattain, M.G., Hutson, A., French, R., Johnson, C.S. Clin. Cancer Res. (2007)
- A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors. Fakih, M.G., Pendyala, L., Smith, P.F., Creaven, P.J., Reid, M.E., Badmaev, V., Azrak, R.G., Prey, J.D., Lawrence, D., Rustum, Y.M. Clin. Cancer Res. (2006)
- Gemcitabine-induced rectus abdominus radiation recall. Fakih, M.G. JOP (2006)
- A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Fakih, M.G., Rajput, A., Yang, G.Y., Pendyala, L., Toth, K., Smith, J.L., Lawrence, D.D., Rustum, Y.M. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- CEA monitoring in colorectal cancer. What you should know. Fakih, M.G., Padmanabhan, A. Oncology (Williston Park, N.Y.) (2006)
- Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Fakih, M.G., Wilding, G., Lombardo, J. Clin. Colorectal. Cancer (2006)
- Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors. Fakih, M.G., Creaven, P.J., Ramnath, N., Trump, D., Javle, M., Strychor, S., Repinski, T.V., Zamboni, B.A., Schwarz, J.K., French, R.A., Zamboni, W.C. Clin. Cancer Res. (2005)
- 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction. Fakih, M.G. Oncology (2004)
